Interaction of mitoxantrone with human serum albumin: Spectroscopic and molecular modeling studies

European Journal of Pharmaceutical Sciences

Volumn 35, Issue 5, 2008, Pages 371-382

  Khan, Shahper N ^a   Islam, Barira ^a   Yennamalli, Ragothaman ^b   Sultan, Abdullah ^a   Subbarao, Naidu ^b   Khan, Asad U ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Antitumor; Drug binding pocket; Fluorescence resonance energy transfer; Molecular modeling

Indexed keywords

BAICALIN; BENDROFLUMETHIAZIDE; CHLOROGENIC ACID; DAIDZEIN; DIVALENT CATION; GENISTEIN; HUMAN SERUM ALBUMIN; HYPERIN; MIDAZOLAM; MITOXANTRONE; QUERCETIN; RUTOSIDE; SHIKONIN; THIOPENTAL;

ARTICLE; CIRCULAR DICHROISM; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENCE SPECTROSCOPY; INFRARED SPECTROSCOPY; MOLECULAR DOCKING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; STEADY STATE; STOICHIOMETRY; THERMODYNAMICS;

ALGORITHMS; ANTINEOPLASTIC AGENTS; CIRCULAR DICHROISM; ENERGY TRANSFER; HEMIN; HUMANS; MITOXANTRONE; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMODYNAMICS; TISSUE DISTRIBUTION; TRYPTOPHAN;

EID: 55949121032     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.07.010     Document Type: Article

References (55)

1. Ahmad B., Parveen S., and Khan R.H. Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site. Biomacromolecules 4 (2006) 350-1356
2. Bi S., Ding L., Tian Y., Song D., Zhou X., Liu X., and Zhang H. Investigation of the interaction between flavonoids and human serum albumin. J. Mol. Struct. 703 (2004) 37-45
3. Brunt E., Limberg J., and Derendorf H. High performance liquid chromatographic-assay and erythrocyte partitioning of fleroxacin, a new fluoroquinolon antibiotic. J. Pharm. Biomed. Anal. 8 (1990) 67-71
4. Buttinelli C., Clemenzi A., Borriello G., Denaro F., Pozzilli C., and Fieschi C. Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up. Eur. J. Neurol. 14 (2007) 1281-1287
5. Carter D.C., and Ho J.X. Structure of Serum Albumin. Advances in Protein Chemistry 45 (1994), Academic Press, New York pp. 53-203
6. Chen G.Z., Huang X.Z., Xu J.G., Wang Z.B., and Zheng Z.Z. Method of Fluorescent Analysis. 2nd ed. (1990), Science Press, Beijing pp. 126
7. Chen G.Z., Huang X.Z., Xu J.G., Wang Z.B., and Zheng Z.Z. Method of Fluorescent Analysis. 2nd ed. (1990), Science Press, Beijing pp. 123
8. Chmelik J., and Kalous V. Polarographic investigation of conformational changes of human serum albumin. Bioelectrochem. Bioenerg. 9 (1982) 7-13
9. Clark P., Rachinsky M.R., and Foster J.F. Moving boundary electrophoresis behavior and acid isomerization of human mercaptalbumin. J. Biol. Chem. 237 (1962) 2509-2513
10. Cornbleet M.A., Stuart-Harris R.C., Smith I.E., Coleman R.E., Rubens R.D., Mc Donald M., Mouridsen H.T., Rainer H., van Oosterom A.T., and Smyth J.F. Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients. Eur. J. Cancer. Clin. Oncol. 20 (1984) 1141-1146
11. Curry S., Mandelkow H., Brick P., and Franks N. Crystal structure of human serum albumin complexed with monounsaturated and polyunsaturated fatty acid. Nat. Struct. Biol. 5 (1998) 827-835
12. Dong C., Huang P., and Caughey W.S. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 29 (1990) 3303-3308
13. Epps D.E., Raub T.J., Caiolfa V., Chiari A., and Zamai M. Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein. J. Pharm. Pharmacol. 51 (1998) 41-48
14. Era S., and Sogami M. H-NMR and CD studies on the structural transition of serum albumin in the acidic region-the N → F transition. J. Pept. Res. 52 (1998) 431-442
15. Fehske K.J., Mullar W.E., and Wollart U. The location of drug binding sites in human serum albumin. Biochem. Pharmacol. 30 (1981) 687-692
16. Forster T. In: Sinanoglu O. (Ed). Modern Quantum Chemistry 3 (1996), Academic Press, New York pp. 93-137
17. Gallois L., Fiallo M., and Garnier-Suillerot A. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study. Biochim. Biophys. Acta 1370 (1998) 31-40
18. Gao H., Lei L., Liu J., Qin K., Chen X., and Hu Z. The study on the interaction between human serum albumin and a new reagent with antitumour activity by spectrophotometric methods. J. Photochem. Photobiol. A 167 (2004) 213-221
19. Hagemeister F., Cabanillas F., Coleman M., Gregory S.A., and Zinzani P.L. The role of mitoxantrone in the treatment of indolent lymphomas. Oncologist 10 (2005) 109-150
20. Harmsen B.J., De Bruin S.H., Janssen L.H., Rodrigues de Miranda J.F., and Van Os G.A. pK change of imidazole groups in bovine serum albumin due to the conformational change at neutral pH. Biochemistry 10 (1971) 3217-3221
21. He W.Y., Li Y., Tian J.N., Liu H.X., Hu Z.D., and Chen X.G. Spectroscopic studies on binding of shikonin to human serum albumin. Photochem. Photobiol. 174 (2005) 53-61
22. Job P. Formation and stability of inorganic complexes in solution. Ann. Chim. 9 (1928) 113-203
23. Jones G., Willett P., and Glen R.C. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245 (1995) 43-53
24. Kang J., Liu Y., Xie M.X., Li S., Jiang M., and Wang Y.D. Interactions of human serum albumin with chlorogenic acid and ferulic acid. Biochim. Biophys. Acta 1674 (2004) 205-214
25. Karnaukhova E. Interactions of human serum albumin with retinoic acid, retinal and retinyl acetate. Biochem. Pharmacol. 73 (2007) 901-910
26. Khan M.Y. Direct evidence for involvement of domain III in the N-F transition of bovine serum albumin. Biochem. J. 236 (1986) 307-310
27. Khan S.N., Islam B., and Khan A.U. Probing midazolam interaction with human serum albumin and its effect on structural state of protein. Int. J. Integr. Biol. 1 (2007) 102-112
28. Khan S.N., Islam B., Rajeswari M.R., Usmani H., and Khan A.U. Characterizing the interaction of anesthetic supplement thiopental with human serum albumin. Acta Biochim. Pol. 55 2 (2008) 399-409
29. Kuntz I.D., Blaney J.M., Oatley S.J., Langridge R., and Ferrin T.E. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol. 161 (1982) 269-288
30. Lakowicz J.R., and Weber G. Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules. Biochemistry 12 (1973) 4161-4170
31. Li Y., He W., Liu J., Sheng F., Hu Z., and Chen X. Binding of the bioactive component jatrorrhizine to human serum albumin. Biochim. Biophys. Acta 1722 (2005) 15-21
32. Lloyd J.B.F. Synchronized excitation of fluorescence emission spectra. Nat. Phys. Sci. 231 (1971) 64-65
33. Mahesha H.G., Singh S.A., Srinivasan N., and Rao A.G. A spectroscopic study of the interaction of isoflavones with human serum albumin. FEBS J. 273 (2006) 451-467
34. Martin B.K. Potential effect of the plasma proteins on drug distribution. Nature 207 (1965) 274-276
35. Messori L., Piccioli F., Gabrielli S., Orioli P., Angeloni L., and Di Bugno C. The disaccharide anthracycline MEN 10755 binds human serum albumin to a non-classical drug binding site. Bioorg. Med. Chem. 10 (2002) 3425-3430
36. Miles J.L., Morey E., Crain F., Gross S., San Julian J., and Canady W.J. Inhibition of α-chymotrypsin by diethyl ether and certain alcohols: a new type of competitive inhibition. J. Biol. Chem. 237 (1962) 1319-1322
37. Miller J.N. Recent advances in molecular luminescence analysis. Proc. Anal. Div. Chem. Soc. 16 (1979) 203-208
38. Neidhart J.A., Gochnour D., Roach R.W., Young D., and Steinberg J.A. A comparative trial of mitoxantrone and doxorubicin in patients with minimally pretreated breast cancer. Semin. Oncol. 11 (1984) 11-14
39. Ojingwa J.C., Sphan-Langguth H., and Benet L.Z. Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma. J. Pharmacokinet. Biopharm. 22 (1994) 19-40
40. Pang Y.H., Yang L.L., Shuang S.M., Dong C., and Thompson M. Interaction of human serum albumin with bendroflumethiazide studied by fluorescence spectroscopy. J. Photochem. Photobiol. B 80 (2005) 139-144
41. Quevedo M.A., Moroni G.N., and Brinonl M.C. Human serum albumin binding of novel antiretroviral nucleoside derivatives of AZT. Biochem. Biophys. Res. Commun. 288 (2001) 954-960
42. Rahim S., and Aubry A.F. Location of binding sites on immobilized human serum albumin for some nonsteroidal anti-inflammatory drugs. J. Pharm. Sci. 84 (1995) 949-952
43. Rahman M.H., Maruyama T., Okada T., Yamasaki K., and Otagiri M. Study of interaction of carprofen and its enantiomers with human serum albumin-I. Stereoselective site-to-site displacement of carprofen by ibuprofen. Biochem. Pharmacol. 46 (1993) 1721-1731
44. Ross P.D., and Subramanian S. Thermodynamics of protein association reactions: forces contributing of stability. Biochemistry 20 (1981) 3096-3102
45. Shargel L., and Yu A.B. Applied Biopharmaceutics and Pharmacokinetics. 4th ed. (1999), Appleton-Century-Crafts, Norwalk, CT Chap. 11
46. Shobini J., Mishra A.K., Sandhya K., and Chandra N. Interaction of coumarin derivatives with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies. Spectrochimica. Acta A 57 (2001) 1133-1147
47. Sogami M., Era S., Nagaoka S., and Inouye H. Circular dichroic and fluoropolarimetric studies on tryptophyl residues in acid-induced isomerization of bovine plasma albumin. Int. J. Pept. Protein Res. 19 (1982) 263-269
48. Sudlow G., Birkett D.J., and Wade D.N. Further characterization of specific drug binding site on human serum albumin. Mol. Pharmacol. 12 (1976) 1052-1061
49. Tang K., Qin Y.-M., Lin A.-H., Hu X., and Zou G.-L. Interaction of daunomycin antibiotic with human serum albumin: investigation by resonant mirror biosensor technique, fluorescence spectroscopy and molecular modeling methods. J. Pharma. Biomed. Anal. 39 (2005) 404-410
50. Tsavaris N., Kosmas C., Kavantzas N., Lazaris A., Skopelitis E., Dimitrakopoulos A., Siakantaris M.P., Papalambros E., Diamantis N., Patsouris E., and Pangalis G.A. Breast cancer following curative chemotherapy for non-Hodgkin's lymphoma and the effect of drug resistance proteins to the final outcome. A retrospective study. J. BUON 10 (2005) 71-76
51. Wang R., Lai L., and Wang S. Further development and validation of empirical scoring functions for structure based binding affinity prediction. J. Comput. Aided Mol. Des. 16 (2002) 11-26
52. Ward L.D. Measurement of ligand binding to proteins by fluorescence spectroscopy. Methods Enzymol. 117 (1985) 400-414
53. Witold K.S., Henry H.M., and Dennis C. Determination of protein secondary structure by e-transform infrared spectroscopy: a critical assessment. Biochemistry 32 (1993) 389-394
54. Ying L., Xiaojun Y., Jing J., Xingguo C., and Zhide H. Interaction of rhein with human serum albumin investigation by optical spectroscopic technique and modeling studies. Biochim. Biophys. Acta 1774 (2007) 51-58
55. Zunszain P.A., Ghuman J., Komatsu T., Tsuchida E., and Curry S. Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct. Biol. 3 (2003) 6-14